WB-4101 |
N-(2,3-DIHYDRO-1,4-BENZODIOXIN-3-YLMETHYL)-2-(2,6-DIMETHOXYPHENOXY)ETHANAMINE;HYDROCHLORIDE |
N-(2,3-DIHYDRO-1,4-BENZODIOXIN-3-YLMETHYL)-2-(2,6-DIMETHOXYPHENOXY)ETHANAMINE |
2,3-DIHYDRO-1,4-BENZODIOXIN-3-YLMETHYL-[2-(2,6-DIMETHOXYPHENOXY)ETHYL]AMINE;HYDROCHLORIDE |
(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLMETHYL)(2-(2,6-DIMETHOXYPHENOXY)ETHYL)AMMONIUM CHLORIDE |
BRD-A01493904-003-02-2 |
L000625 |
LS-187404 |
LS-186702 |
HE225911 |
NCGC00024893-03 |
NCGC00024893-02 |
NCGC00015318-05 |
NCGC00015318-04 |
NCGC00015318-03 |
CCG-204430 |
DNC003793 |
AR-1B7485 |
EINECS 218-520-3 |
AC1Q7017 |
KST-1B6409 |
MOLPORT-035-936-381 |
CID_11957505 |
KBIO3_001710 |
KBIO2_007447 |
KBIO2_004879 |
KBIO2_002311 |
BDBM69602 |
2170-58-3 (HYDROCHLORIDE) |
613-67-2 (PARENT) |
SPBIO_001510 |
SCHEMBL800982 |
KBIOSS_002313 |
KBIOGR_001646 |
GTPL499 |
BSPBIO_002490 |
LOPAC0_000335 |
SPECTRUM5_001831 |
SPECTRUM4_001213 |
SPECTRUM3_000785 |
SPECTRUM2_001575 |
AC1L1KWN |
SMR000326775 |
SPECTRUM_001815 |
1,4-BENZODIOXIN-2-METHANAMINE, N-(2-(2,6-DIMETHOXYPHENOXY)ETHYL)-2,3-DIHYDRO- |
MLS000859914 |
613-67-2 |
N-(2-(2,6-DIMETHOXYPHENOXY)ETHYL)-2,3-DIHYDRO-1,4-BENZODIOXIN-2-METHANAMINE |
N-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLMETHYL)-2-(2,6-DIMETHOXYPHENOXY)ETHANAMINE |
1,4-BENZODIOXIN-2-METHANAMINE, N-[2-(2,6-DIMETHOXYPHENOXY)ETHYL]-2,3-DIHYDRO- |
(2-(2',6'-DIMETHOXY)PHENOXYETHYLAMINO)METHYLBENZODIOXAN |
(2-(2',6'-DIMETHOXY)PHENOXYETHYLAMINO)METHYLBENZO-1,4-DIOXANE |
CHEBI:64098 |
WB 4101 |
WB4101 |
5685 |
135651323 |
499 |
antagonist |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
WB 4101 | GuideToPharmacology Ligand Name |
135651323 | PubChem Drug SID |
WB-4101 | pubchem_primary_name |
5685 | PubChem CID |
WB4101 | Drug Synonym |